Hepatic function and physiology in the newborn

S V Beath1

  • 1The Liver Unit, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.

Insights

Liver development is complex, with full maturity achieved two years post-birth. Neonatal liver dysfunction risks include immaturity, hypoxia, and sepsis, with potential links to fatty liver disease.

Area of Science:

  • Hepatology
  • Developmental Biology
  • Neonatal Medicine

Background:

  • Liver development progresses from progenitor cells, with bile secretion by 12 weeks' gestation.
  • Hepatocyte specialization occurs at birth, with distinct sinusoidal and canalicular surfaces for nutrient absorption and bile/metabolite transport.
  • Postnatal interruption of umbilical supply rapidly induces key liver functions like transamination and coagulation factor synthesis.

Purpose of the Study:

  • To review liver development from progenitor cells to mature organ.
  • To highlight functional and anatomical specialization of the liver acinus.
  • To discuss risks and causes of neonatal liver dysfunction and potential long-term implications.

Main Methods:

  • Literature review of liver development and function.
  • Discussion of signaling pathways (e.g., JAG1) and genetic factors.
  • Analysis of neonatal liver risks and emerging concepts like neonatal fatty liver disease.

Main Results:

  • Liver maturity is achieved up to two years after birth, involving complex signaling pathways.
  • Hepatocytes exhibit specialized functions and anatomical zonation (Zones 1, 2, 3) within the hepatic acinus.
  • Preterm infants face increased risks of hepatic decompensation due to immature detoxifying and synthetic functions.

Conclusions:

  • Neonatal liver immaturity, hypoxia, and sepsis are significant causes of liver dysfunction.
  • Stem cell and genetic research offer insights into liver development and regeneration.
  • The neonatal period may be critical for the development of conditions like non-alcoholic steatohepatitis (NASH).

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...